Clinical Edge Journal Scan

Integrating ultrasound with CASPAR improves diagnosis of PsA


 

Key clinical point: The a ddition of ultrasound-detected features, such as tenosynovitis and enthesitis, to the CASPAR (ClASsification criteria for Psoriatic Arthritis) scoring system improved its diagnostic utility.

Major finding: Specificity improved (84.0% to 91.4%) and sensitivity was similar (94.5% to 95.7%) after ultrasound features, such as tenosynovitis and enthesitis, were integrated in the original CASPAR criteria which had been based on physical examination.

Study details: Findings are from a cross-sectional study including 326 participants, of which 164 were diagnosed with PsA .

Disclosures: This study was supported by the Interdisciplinary Clinical Research Project of the Peking University First Hospital, China, and other sources. The authors declared no conflict of interests.

Source: Geng Y et al. Improved diagnostic performance of CASPAR criteria with integration of ultrasound. Front Immunol. 2022;13:935132 (Oct 10). Doi: 10.3389/fimmu.2022.935132

Recommended Reading

Commentary: Drug efficacy and comorbid factors in PsA, November 2022
MDedge Rheumatology
Therapeutic drug monitoring pays off for arthritis patients
MDedge Rheumatology
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
MDedge Rheumatology
New ACR vaccination guideline: Take your best shot
MDedge Rheumatology
Long-term efficacy and safety of risankizumab in PsA patients with inadequate response to csDMARD
MDedge Rheumatology
Increased risk for preeclampsia in women with PsA
MDedge Rheumatology
Upadacitinib as effective and safe as adalimumab in the long term treatment of PsA
MDedge Rheumatology
Etanercept slows radiographic progression of PsA in the real world
MDedge Rheumatology
Higher prevalence of sonographic enthesitis in men than in women with PsA
MDedge Rheumatology
Greater odds of metabolic syndrome and cardiovascular disease in PsA vs RA
MDedge Rheumatology